Form D — Consano Bio, Inc.
0001981285-26-000001 · filed Mar 20, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $48,858,795
- Reported amount sold
- $34,824,466
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Consano Bio, Inc.
- CIK
- 1981285
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 100 SUMMIT DRIVE
BURLINGTON, Massachusetts 01803 - Phone
- 617-798-4559
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Andrew Hall · Executive OfficerBurlington, Massachusetts Find on LinkedIn ↗
-
Jennifer Schmitke · Executive OfficerBurlington, Massachusetts Find on LinkedIn ↗
-
Doug Vander Weide · DirectorBurlington, Massachusetts Find on LinkedIn ↗
-
Christopher Centeno · DirectorBurlington, Massachusetts Find on LinkedIn ↗
-
Bill Abbington · DirectorBurlington, Massachusetts Find on LinkedIn ↗
-
Jerome Adams · DirectorBurlington, Massachusetts Find on LinkedIn ↗
-
Michael Pede · DirectorBurlington, Massachusetts Find on LinkedIn ↗
-
Joe Schiesl · DirectorBurlington, Massachusetts Find on LinkedIn ↗
-
John Conway · DirectorBurlington, Massachusetts Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗